131 related articles for article (PubMed ID: 26122034)
1. SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease.
Han D; Wang J; Ma S; Chen Y; Cao F
Curr Drug Targets; 2017; 18(15):1746-1753. PubMed ID: 26122034
[TBL] [Abstract][Full Text] [Related]
2. Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury.
Ma J; Yang L; Ma Y; Wang X; Ren J; Yang J
Curr Drug Targets; 2017; 18(15):1733-1745. PubMed ID: 26477459
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 confers protection against ischemia/reperfusion injury in cardiomyocytes via regulation of uncoupling protein 2 expression.
Deng M; Wang D; He S; Xu R; Xie Y
Mol Med Rep; 2017 Nov; 16(5):7098-7104. PubMed ID: 28901505
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion.
Ding X; Zhu C; Wang W; Li M; Ma C; Gao B
Pharmacol Res; 2024 Jan; 199():106957. PubMed ID: 37820856
[TBL] [Abstract][Full Text] [Related]
5. ER stress-induced apoptosis: A novel therapeutic target in myocardial ischemia and reperfusion injury.
Wang J; Hu X; Jiang H
Int J Cardiol; 2016 Jul; 214():233-4. PubMed ID: 27077539
[No Abstract] [Full Text] [Related]
6. Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes.
Guo Y; Zhang L; Li F; Hu CP; Zhang Z
Eur J Pharmacol; 2016 Apr; 776():26-33. PubMed ID: 26921129
[TBL] [Abstract][Full Text] [Related]
7. Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress.
Tong C; Morrison A; Mattison S; Qian S; Bryniarski M; Rankin B; Wang J; Thomas DP; Li J
FASEB J; 2013 Nov; 27(11):4332-42. PubMed ID: 23024374
[TBL] [Abstract][Full Text] [Related]
8. Sirtuin 1 activated by SRT1460 protects against myocardial ischemia/reperfusion injury.
Zhao S; Yu L
Clin Hemorheol Microcirc; 2021; 78(3):271-281. PubMed ID: 33682700
[TBL] [Abstract][Full Text] [Related]
9. Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin.
Yu L; Liang H; Dong X; Zhao G; Jin Z; Zhai M; Yang Y; Chen W; Liu J; Yi W; Yang J; Yi D; Duan W; Yu S
J Pineal Res; 2015 Oct; 59(3):376-90. PubMed ID: 26327197
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
Zhang Y; Liu X; She ZG; Jiang DS; Wan N; Xia H; Zhu XH; Wei X; Zhang XD; Li H
Basic Res Cardiol; 2014; 109(5):434. PubMed ID: 25150882
[TBL] [Abstract][Full Text] [Related]
11. Bakuchiol attenuates myocardial ischemia reperfusion injury by maintaining mitochondrial function: the role of silent information regulator 1.
Feng J; Yang Y; Zhou Y; Wang B; Xiong H; Fan C; Jiang S; Liu J; Ma Z; Hu W; Li T; Feng X; Xu J; Jin Z
Apoptosis; 2016 May; 21(5):532-45. PubMed ID: 27000151
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury.
Cheng Y; Di S; Fan C; Cai L; Gao C; Jiang P; Hu W; Ma Z; Jiang S; Dong Y; Li T; Wu G; Lv J; Yang Y
Apoptosis; 2016 Aug; 21(8):905-16. PubMed ID: 27270300
[TBL] [Abstract][Full Text] [Related]
13. Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes.
Zhao D; Yang J; Yang L
Oxid Med Cell Longev; 2017; 2017():6437467. PubMed ID: 28298952
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats.
Ding M; Lei J; Han H; Li W; Qu Y; Fu E; Fu F; Wang X
Cardiovasc Diabetol; 2015 Oct; 14():143. PubMed ID: 26489513
[TBL] [Abstract][Full Text] [Related]
15. Alterations of SIRT1/SIRT3 subcellular distribution in aging undermine cardiometabolic homeostasis during ischemia and reperfusion.
Zhang J; Wang H; Slotabec L; Cheng F; Tan Y; Li J
Aging Cell; 2023 Sep; 22(9):e13930. PubMed ID: 37537789
[TBL] [Abstract][Full Text] [Related]
16. SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia-reperfusion injury.
Yang G; Zhang X; Weng X; Liang P; Dai X; Zeng S; Xu H; Huan H; Fang M; Li Y; Xu D; Xu Y
Basic Res Cardiol; 2017 May; 112(3):22. PubMed ID: 28271186
[TBL] [Abstract][Full Text] [Related]
17. Multidrug prevention or therapy of ischemia-reperfusion injury of the heart-Mini-review.
Krzywonos-Zawadzka A; Franczak A; Sawicki G; Woźniak M; Bil-Lula I
Environ Toxicol Pharmacol; 2017 Oct; 55():55-59. PubMed ID: 28826125
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions.
Wu Y; Xia ZY; Zhao B; Leng Y; Dou J; Meng QT; Lei SQ; Chen ZZ; Zhu J
Int J Mol Med; 2017 Aug; 40(2):389-399. PubMed ID: 28714516
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
